Search clinical trials for: 5mg Olanzapine

Total 12777 results

Mitsubishi Tanabe Pharma America Inc.

Completed

MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women

Menopause Hot Flashes

United States
Centre for Addiction and Mental Health

Recruiting

Effects of Antipsychotics on Brain Insulin Action in Females

Insulin Resistance | Type 2 Diabetes | Menstrual Cycle | Antipsychotics

Canada
Eli Lilly and Company

Completed

Comparing the Effect of Under the Tongue Olanzapine Versus Swallowed Olanzapine on Body Mass Index (A Ratio of Weight to Height)

Schizophrenia | Schizoaffective Disorder | Bipolar Disorder

United States, Puerto Rico, Netherlands, Canada, Mexico
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Recruiting

A Study of HS-20094 in T2DM Participants

Type 2 Diabetes

China
The University of Hong Kong
Queen Elizabeth Hospital, Hong Kong

Terminated

Oral Olanzapine Versus Haloperidol or Diazepam

Acute Agitation | Behavioural Emergency

Hong Kong
Pfizer's Upjohn has merged with Mylan to form Viatris...

Terminated

Ziprasidone And Olanzapine's Outcomes In Mania (ZOOM)

Acute Mania | Bipolar Disorder, Manic

Turkey, Italy, Germany, Greece, Spain
Neuropsychiatric Research Institute, Fargo, North...
Eli Lilly and Company; University of North Dakota

Completed

Effects of Modafinil on Olanzapine Weight Gain

Weight Gain

United States
Newish Technology (Beijing) Co., Ltd.

Recruiting

NWRD06 DNA Plasmid for HCC After Radical Resection

Hepatocellular Carcinoma

China
Ottawa Hospital Research Institute

Completed

Individualised Versus Standard Care for Breast Cancer Patients at High-risk for Chemotherapy-induced Nausea and Vomiting The ILIAD Study

Breast Cancer

Canada
Eli Lilly and Company

Completed

A Study Comparing Rapid Acting Intramuscular Olanzapine and Placebo in Agitated Patients With Schizophrenia

Schizophrenia

Japan
UNC Lineberger Comprehensive Cancer Center
University of North Carolina, Chapel Hill

Completed

Olanzapine for Nausea/Vomiting Prophylaxis in Recipients of Hematopoietic Stem Cell Transplants

Chemotherapy-induced Nausea and Vomiting

United States
Seattle Institute for Biomedical and Clinical Research
Eli Lilly and Company

Active, not recruiting

Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine

Obesity | Schizophrenia | Schizoaffective Disorder | Metabolic Syndrome | Bipolar Disorder

United States
Dr. Reddy's Laboratories Limited

Completed

Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fasting Condition

Fasting

India
Dr. Reddy's Laboratories Limited

Completed

Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fed Condition

Fed

India
Central Institute of Mental Health, Mannheim
Ludwig-Maximilians - University of Munich; Heidelberg University; Technical University... and other collaborators

Active, not recruiting

A Four-week Clinical Trial Investigating Efficacy and Safety of Cannabidiol as a Treatment for Acutely Ill Schizophrenic Patients

Schizophrenia

Germany, Denmark
Yonsei University

Unknown

Clinical Trials to Compare the Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Significant Hepatic Fibrosis With Type 2 Diabetes

Chronic Hepatitis B With Significant Hepatic Fibrosis With Type 2 Diabetes

Korea, Republic of
Matias Vested

Not yet recruiting

Neuromuscular Monitoring in Children (6 Months - 2 Years) With Electromyography and Acceleromyography

Neuromuscular Blockade

Denmark
University Hospital Ulm

Recruiting

Does Electromyography Improve Precision and Reliability of Neuromuscular Monitoring in Paediatric Patients (ETCETERA)

Postoperative Complications | Neuromuscular Blockade, Residual

Germany
AstraZeneca

Completed

To Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib in Patients With Hepatic Impairment and Healthy Subjects

Solid Tumors

United States
Vanderbilt University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Selenium Supplementation of Patients With Cirrhosis

Liver Cirrhosis | Healthy

United States
Boryung Pharmaceutical Co., Ltd

Completed

A Multi Doses Study to Compare the Pharmacokinetics of BR9003A and BR9003 in Healthy Adult Subjects

Smoking Cessation

Korea, Republic of
Daewon Pharmaceutical Co., Ltd.

Completed

Phase 1 Study of DDI Between DW330SR and DW1030 in Healthy Male Subjects

Healthy

Korea, Republic of
Qinghai Red Cross Hospital

Recruiting

Survival With Olanzapine in Patients With Locally Advanced or Metastatic Upper Gastrointestinal and Lung Cancer

Advanced Cancer | Progression Free Survival | Olanzapine

China
Cairo University

Recruiting

Olanzapine Anorexia Cachexia

Anorexia

Egypt
Centre for Addiction and Mental Health

Recruiting

"Extended" (Alternate Day) Antipsychotic Dosing

Drug Therapy | Schizophrenia and Related Disorders | Antipsychotic Agents | Drug Administration Schedule

Canada
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Unknown

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Food Effect of SYHA1402 in Healthy Subjects

Diabetic Peripheral Neuropathy
Pfizer

Terminated

A Study To Examine Safety, Pharmacokinetics, And Pharmacodynamic Of Pf 06412562 In Healthy Males

Healthy

United States
Mitsubishi Tanabe Pharma Corporation

Completed

A Pharmacokinetic Study of MP-214 in Patients With Schizophrenia

Schizophrenia

Japan
CR-CSSS Champlain-Charles-Le Moyne

Completed

Feasibility of Olanzapine at REduced doSe in hIGHly Emetogenic chemoTherapy (FORESIGHT)

Chemotherapy-induced Nausea and Vomiting

Canada
Samjin Pharmaceutical Co., Ltd.

Completed

A Phase 4 Clinical Study to Investigate the Efficacy and Safety of Naloxone HCI IV in Patients With Stroke

Stroke, Acute

Korea, Republic of
Hansoh BioMedical R&D Company

Recruiting

A Study to Evaluate Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis

Psoriasis

China
Shanghai Henlius Biotech

Active, not recruiting

A Clinical Study Evaluating the Use of HLX10 in Combination With HLX04 for the Treatment of Advanced Hepatocellular Carcinoma (HCC) Patients

Hepatocellular Carcinoma

China
University Hospital, Basel, Switzerland

Recruiting

Effect of Ketanserin, Olanzapine, and Lorazepam After LSD Administration on the Acute Response to LSD in Healthy Subjects (LBL)

Healthy

Switzerland
Richard Hall
Dalhousie University

Terminated

Haloperidol vs Olanzapine for the Management of ICU Delirium

Delirium | Agitation

Canada
Thomas Jefferson University
Eli Lilly and Company

Terminated

A Research Study Examining the Use of Olanzapine for the Prevention of Migraine

Migraine

United States
Percheron Therapeutics

Active, not recruiting

A Study of ATL1102 or Placebo in Participants With Non-ambulatory Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy

United Kingdom, Australia, Serbia, Turkey, Bulgaria
Joint Stock Company "Farmak"

Completed

Fasted Bioequivalence Study of 2 Olanzapine Film-coated Tablets, 5 mg, in Healthy, Adult Male and Female Subjects.

Pharmacokinetics

Czechia
Gannex Pharma Co., Ltd.

Recruiting

Study to Evaluate the Safety, Tolerability, and Efficacy of ASC41 Tablets in Adult Patients With NASH

Non-alcoholic Fatty Liver Disease | Non-alcoholic Steatohepatitis

China
Boehringer Ingelheim
Eli Lilly and Company

Completed

30 Week Parallel Group Comparison Study of Linagliptin + Pioglitazone (5+15, 5+30 and 5+45 mg) qd Versus Respective Monotherapies, Followed by a Comparison of 5mg+30mg and 5mg+45mg Versus Respective Monotherapies in Type 2 Diabetes for up to 54 Weeks

Diabetes Mellitus, Type 2

United States, Estonia, Germany, Latvia, Spain, United Kingdom
LG Chem

Completed

An Ascending Dose, Single/Multiple Dosing, Food Effect Clinical Trial to Evaluate Pharmacokinetics, Safety and Tolerability in Healthy Subjects After Oral Administration of Gemigliptin (Phase I)

Type 2 Diabetes Mellitus

China
Milton S. Hershey Medical Center
American Medical Association

Completed

A Crossover Study of the Acute Effects of Olanzapine in Healthy Volunteers

Diabetes Mellitus | Insulin Resistance

United States
J2H Biotech

Completed

Phase 1 Study to Investigate Safety, Tolerability, PK/PD of J2H-1702 in Healthy Females

Non-alcoholic Steatohepatitis

Korea, Republic of
Sunovion

Completed

A Study to Evaluate a Drug (Dasotraline) on the Safety, Effectiveness and How Well the Body Tolerates it, in Adults With Moderate to Severe Binge Eating Disorder

Binge Eating Disorder

United States
Medicines for Malaria Venture
Asociacion Civil Selva Amazonica

Completed

DSM265 Phase IIa Investigation Treating Plasmodium Falciparum or Vivax

Plasmodium Falciparum Malaria | Plasmodium Vivax Malaria

Peru
Teva Pharmaceuticals USA

Completed

A Relative Bioavailability Study of 200mg/5 mL Azithromycin Oral Suspension Under Non-Fasting Conditions

Healthy

United States
Abalonex, LLC

Not yet recruiting

Safety and Efficacy of ABX-101 in Participants Aged 18 to 50 Years of Age With Moderate to Severe Traumatic Brain Injury

Traumatic Brain Injury | Cerebral Edema
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Completed

Study on Safety, Absorption and Metabolism of SYHA1402 Tablets in Healthy People

Diabetic Neuropathy Peripheral

China
Rigel Pharmaceuticals

Completed

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma (SITAR)

Asthma

United States, Canada
University of North Carolina, Chapel Hill
Eli Lilly and Company

Completed

Study of Amantadine for Weight Stabilization During Olanzapine Treatment

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder | Psychotic Disorder | Mood Disorders With Psychotic Features

United States
Meir Medical Center

Completed

Combined THC and CBD Drops for Treatment of Crohn's Disease

Crohn's Disease

Israel

Search clinical trials for: 5mg Olanzapine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Morocco

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations